dc.contributor.author | Dalli, J | en_US |
dc.contributor.author | Gomez, EA | en_US |
dc.date.accessioned | 2023-12-18T16:18:03Z | |
dc.date.available | 2023-09-18 | en_US |
dc.date.issued | 2023-11-10 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/93002 | |
dc.format.extent | 7293 - ? | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Nat Commun | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Humans | en_US |
dc.subject | Docosahexaenoic Acids | en_US |
dc.subject | Inflammation | en_US |
dc.title | Reply to: Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples. | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1038/s41467-023-41767-9 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/37949899 | en_US |
pubs.issue | 1 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
pubs.volume | 14 | en_US |
dcterms.dateAccepted | 2023-09-18 | en_US |
qmul.funder | Sir Henry Dale Fellowship::Wellcome Trust | en_US |
qmul.funder | Sir Henry Dale Fellowship::Wellcome Trust | en_US |